<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27982348</article-id><article-id pub-id-type="pmc">5144561</article-id><article-id pub-id-type="doi">10.5935/1678-9741.20160078</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>A Cycle Ergometer Exercise Program Improves Exercise Capacity and
Inspiratory Muscle Function in Hospitalized Patients Awaiting Heart
Transplantation: a Pilot Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Forestieri</surname><given-names>Patr&#x000ed;cia</given-names></name><degrees>PT, MSc</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Guizilini</surname><given-names>Solange</given-names></name><degrees>PT, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Peres</surname><given-names>Monique</given-names></name><degrees>PT</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bublitz</surname><given-names>Caroline</given-names></name><degrees>PT</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bolzan</surname><given-names>Douglas W.</given-names></name><degrees>PT, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rocco</surname><given-names>Isadora S.</given-names></name><degrees>PT</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Santos</surname><given-names>Vin&#x000ed;cius B.</given-names></name><degrees>RN, MSc</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Moreira</surname><given-names>Rita Simone L.</given-names></name><degrees>RN, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Breda</surname><given-names>Jo&#x000e3;o R.</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>de Almeida</surname><given-names>Dirceu R.</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Carvalho</surname><given-names>Antonio Carlos de C.</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Arena</surname><given-names>Ross</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Gomes</surname><given-names>Walter J.</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Disciplina de Cirurgia Cardiovascular e Cardiologia da
Escola Paulista de Medicina da Universidade de S&#x000e3;o Paulo (EPM-UNIFESP),
S&#x000e3;o Paulo, SP, Brazil.</aff><aff id="aff2"><label>2</label>Departamento de Ci&#x000ea;ncia do Movimento Humana,
Escola de Fisioterapia da Universidade Federal de S&#x000e3;o Paulo (UNIFESP),
Santos, SP, Brazil.</aff><aff id="aff3"><label>3</label>Department of Physical Therapy and Integrative Physiology
Laboratory, College of Applied Health Sciences, University of Illinois at Chicago,
Chicago, USA.</aff><author-notes><corresp id="c1">Correspondence Address: Solange Guizilini,
Universidade Federal de S&#x000e3;o Paulo - Rua Napole&#x000e3;o de
Barros, 715, 3&#x000b0; andar - Vila Clementino - S&#x000e3;o Paulo, SP, Brazil - Zip
code: 04024-002. E-mail: <email>sguizilini@unifesp.br</email></corresp><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></author-notes><pub-date pub-type="epub-ppub"><season>Sep-Oct</season><year>2016</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Sep-Oct</season><year>2016</year></pub-date><volume>31</volume><issue>5</issue><fpage>389</fpage><lpage>395</lpage><history><date date-type="received"><day>09</day><month>8</month><year>2016</year></date><date date-type="accepted"><day>15</day><month>9</month><year>2016</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>The purpose of this study was to evaluate the effect of a cycle ergometer
exercise program on exercise capacity and inspiratory muscle function in
hospitalized patients with heart failure awaiting heart transplantation with
intravenous inotropic support.</p></sec><sec><title>Methods</title><p>Patients awaiting heart transplantation were randomized and allocated
prospectively into two groups: 1) Control Group (n=11) - conventional
protocol; and 2) Intervention Group (n=7) - stationary cycle ergometer
exercise training. Functional capacity was measured by the six-minute walk
test and inspiratory muscle strength assessed by manovacuometry before and
after the exercise protocols.</p></sec><sec><title>Results</title><p>Both groups demonstrated an increase in six-minute walk test distance after
the experimental procedure compared to baseline; however, only the
intervention group had a significant increase (<italic>P</italic>=0.08 and
<italic>P</italic>=0.001 for the control and intervention groups,
respectively). Intergroup comparison revealed a greater increase in the
intervention group compared to the control (<italic>P</italic>&#x0003c;0.001).
Regarding the inspiratory muscle strength evaluation, the intragroup
analysis demonstrated increased strength after the protocols compared to
baseline for both groups; statistical significance was only demonstrated for
the intervention group, though (<italic>P</italic>=0.22 and
<italic>P</italic>&#x0003c;0.01, respectively). Intergroup comparison showed
a significant increase in the intervention group compared to the control
(<italic>P</italic>&#x0003c;0.01).</p></sec><sec><title>Conclusion</title><p>Stationary cycle ergometer exercise training shows positive results on
exercise capacity and inspiratory muscle strength in patients with heart
failure awaiting cardiac transplantation while on intravenous inotropic
support.</p></sec></abstract><kwd-group><kwd>Heart Failure</kwd><kwd>Heart Transplantation</kwd><kwd>Respiratory Mechanics</kwd><kwd>Muscle Strength/*Physiology</kwd><kwd>Respiratory Therapy/*Methods</kwd></kwd-group></article-meta></front><body><table-wrap id="t3" orientation="portrait" position="anchor"><table frame="hsides" rules="groups" style="background-color:#e6e7e8"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Abbreviations, acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>6MWT</bold></td><td align="left" rowspan="1" colspan="1"><bold>=Six-minute walk test</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>ATS</bold></td><td align="left" rowspan="1" colspan="1"><bold>=American Thoracic Society</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>CR</bold></td><td align="left" rowspan="1" colspan="1"><bold>=Cardiac rehabilitation</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>HF</bold></td><td align="left" rowspan="1" colspan="1"><bold>=Heart failure</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>MIP</bold></td><td align="left" rowspan="1" colspan="1"><bold>=Maximal inspiratory pressure</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>NYHA</bold></td><td align="left" rowspan="1" colspan="1"><bold>=New York Heart Association</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>PEB</bold></td><td align="left" rowspan="1" colspan="1"><bold>=Perceived exertion Borg</bold></td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Despite significant advances in clinical therapy, heart failure (HF) remains a
primary reason for hospitalizations and morbidity and mortality<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. Histological, metabolic and
functional adaptations induced by HF promote a decrease in inspiratory and
peripheral muscles strength and endurance, leading to exercise
intolerance<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. Inspiratory
(present in 30% to 50% of the HF patients) and global peripheral muscle
weakness<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup> are associated
with reduced functional capacity, impaired quality of life, and poor
prognosis<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>.</p><p>Consistent scientific evidence has shown that aerobic exercise training is an
efficient nonpharmacological tool for HF management<sup>[<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref>]</sup>. However,
evidence related to exercised-based cardiac rehabilitation (CR) involving
hospitalized HF patients requires further examination. In addition, decreased
mobility associated with prolonged bed rest during hospitalization could potentiate
the detrimental effects of HF<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>.
For this reason, the early establishment of exercise training is advantageous.</p><p>Although optimal drug therapy is initiated in the hospital setting during the acute
decompensation period (<italic>i.e.</italic>, intravenous inotropic), many patients
become refractory to conventional therapy, requiring consideration for heart
transplantation<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>.
Moreover, after being listed as an appropriate candidate for this surgical
procedure, therapeutic management in the pre-transplant phase may be delicate and
taxing<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>; the main
objective during this pre-surgical phase is to avoid further deterioration and
death.</p><p>Despite the well-established safety and efficacy of exercise training in stable
outpatients with HF, the impact of exercise in end-stage HF patients awaiting heart
transplantation while on intravenous positive inotropic support remains largely
unreported<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>. Therefore,
the purpose of this study was to evaluate the effects of a stationary cycle
ergometer program on exercise capacity and inspiratory muscle function in
hospitalized patients awaiting heart transplantation on intravenous inotropic
support.</p></sec><sec sec-type="methods"><title>METHODS</title><p>This study was conducted at S&#x000e3;o Paulo Hospital - Federal University of Sao
Paulo. The Institutional Ethics Committee approved this study and a written informed
consent was obtained from all patients after explanation of the purpose and
procedures of the study.</p><sec><title>Subjects</title><p>For this prospective study, patients hospitalized with end-stage HF awaiting
heart transplantation were recruited. Patients were considered eligible
according to the following criteria: both genders; between 18 and 65 years of
age; and with HF diagnosis determined by the referring clinicians on the basis
of clinical presentation [New York Heart Association (NYHA) classes III and IV]
and confirmed by echocardiography.</p><p>Patients with unstable angina pectoris, acute coronary syndromes, atrial and
ventricular arrhythmias leading to hemodynamic compromise, chronic renal failure
or dialysis, neuromuscular and psychiatric conditions that could potentially
interfere with performance on the 6-minute walk test (6MWT), and those in need
of non-invasive ventilation support during exercise were excluded. Patients with
chronic lung disease confirmed by pulmonary function testing according to the
American Thoracic Society (ATS) were also excluded<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>.</p><p>All patients received an individually optimized medical treatment, including
intravenous inotropic support, angiotensin-converting enzyme inhibitors,
aldosterone antagonists and other diuretics.</p></sec><sec><title>Randomization and Blinding Procedures</title><p>The randomization procedure was performed through a computer program and
allocation secrecy was kept by numbered, sealed, opaque envelopes. The patients
were randomized into two groups: 1) Control Group (n=11) - conventional
protocol; and 2) Intervention Group (n=7) - stationary cycle ergometer exercise
program.</p></sec><sec><title>Procedures</title><p>The study protocol was initiated 24 hours after hospital admission or clinical
stabilization, and consisted of two different exercise protocols, applied twice
a day during hospitalization. Regardless of group allocation, all patients were
able to walk unaided for short distances (<italic>e.g.</italic>, from the bed to
the bathroom) and were instructed to sit upright in a chair at least twice a day
outside of sessions associated with the protocol.</p><p>Patients were familiarized with a perceived exertion Borg (PEB) scale prior to
each exercise session, and were instructed to exercise at a PEB scale rating of
3-4 ('moderate' to 'somewhat strong').</p></sec><sec><title>Study Protocols</title><p>Control Group - each session consisted of breathing exercises and global active
exercises of the upper and lower limbs while in the upright seated position.</p><p>Intervention Group - each session included stationary cycle ergometer exercise
(Mini bike E5, Acte Brazil - lower extremity) while in the upright seated
position for 20 minutes. The protocol was performed intermittently with 5
periods; each period consisted of 3 minutes of cycling followed by 1-minute of
rest (<xref ref-type="fig" rid="f1">Figure 1</xref>).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Intermittent protocol: stationary cycle ergometer exercise
training.</p></caption><graphic xlink:href="rbccv-31-05-0389-g01"/></fig>
</p></sec><sec><title>Measurements and Outcomes</title><sec><title>Inspiratory Muscle Strength Evaluation</title><p>Evaluation of respiratory muscle strength consisted of measuring the maximal
inspiratory pressure (MIP) by an analog manovacuometer (GerAr
med<sup>&#x000ae;</sup>. The recordings were performed for both pre
and post training protocols. Each maneuver was performed five times with 1
minute rest between them, and sustained pressure during 2 seconds by the
patient was recorded according to established guidelines<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. MIP was measured from
residual volume; the patient was requested to perform a forced expiration
and then take a maximal inspiratory effort against an occluded airway
(Mueller maneuver). The prediction equation proposed by Neder et
al.<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup> was used
to predict maximal inspiratory pressure for all patients.</p></sec><sec><title>Submaximal Functional Capacity Assessment</title><p>All patients underwent a 6MWT to assess their baseline submaximal functional
capacity, which was performed according to ATS standards<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup> by an evaluator blinded
to group allocation. The prediction equation proposed by Iwama et
al.<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup> was used
to predict walking distances for all patients. The follow-up 6MWT was
conducted approximately 3 weeks later, immediately following protocol
completion. During the test, all patients were on intravenous inotropic
support administered by an infusion pump, which was carried out by the same
blinded evaluator who walked at the patient's side.</p></sec><sec><title>Exercise Interruption Criteria</title><p>The exercise protocol or the 6MWT was discontinued if the subject presented
signs of exercise intolerance, such as low cardiac output
(<italic>i.e.</italic>, cyanosis, pallor and nausea), bradycardia, a
drop in systolic blood pressure of &#x0003e;15 mmHg in comparison to baseline, an
excessive rise in systolic blood pressure defined as &#x0003e; 200 mmHg, a rise
in diastolic blood pressure during exercise &#x0003e;110 mmHg, chest pain or
symptoms of fatigue.</p></sec><sec><title>Statistical Analysis</title><p>Data were reported as mean &#x000b1; standard deviation. Normal
distribution for all variables was verified using the Kolmogorov-Smirnov
test. When variables were compared between groups, the unpaired Student's
t-test and Mann-Whitney test were used as appropriate. For intragroup
analysis, the paired Student's t-test was used. Categorical variables were
analyzed by the Pearson Chi-square test. The Pearson correlation coefficient
was used to evaluate associations of interest. A <italic>P</italic>-value
of &#x0003c;0.05 was considered statistically significant for all tests.
Statistical analyses were performed using GraphPad Prism 6.0 Software
(GraphPad Software Inc, San Diego, CA, USA).</p></sec></sec></sec><sec sec-type="results"><title>RESULTS</title><p>A flow-chart illustrating progression of patients through the study is shown in <xref ref-type="fig" rid="f2">Figure 2</xref>. The groups were homogeneous and no
statistical difference was found when comparing baseline demographic and clinical
characteristics, as shown in <xref ref-type="table" rid="t1">Table 1</xref>.</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Flowchart of subject recruitment, enrollment, randomization and
completion. 6MWT= 6-minute walk test.</p></caption><graphic xlink:href="rbccv-31-05-0389-g02"/></fig>
</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Patients&#x02019; baseline characteristics.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">Control Group <break/>(n=11)</th><th align="center" rowspan="1" colspan="1">Intervention Group <break/>(n=7)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">45&#x000b1;11.2</td><td align="center" rowspan="1" colspan="1">48.3&#x000b1;10.2</td><td align="center" rowspan="1" colspan="1">0.44</td></tr><tr><td align="left" rowspan="1" colspan="1">Female/Male(n)</td><td align="center" rowspan="1" colspan="1">02/9</td><td align="center" rowspan="1" colspan="1">2/5</td><td align="center" rowspan="1" colspan="1">0.60</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">22.3&#x000b1;3.0</td><td align="center" rowspan="1" colspan="1">24.2&#x000b1;3.1</td><td align="center" rowspan="1" colspan="1">0.08</td></tr><tr><td align="left" rowspan="1" colspan="1">Etiology (n)</td><td align="center" rowspan="1" colspan="1">7 ischemic</td><td align="center" rowspan="1" colspan="1">5 ischemic</td><td align="center" rowspan="1" colspan="1">0.35</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">1 idiopathic</td><td align="center" rowspan="1" colspan="1">1 idiopathic</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">3 hypertensive</td><td align="center" rowspan="1" colspan="1">1 non-compact myocardium</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">ICD / pacemaker (n)</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0.55</td></tr><tr><td align="left" rowspan="1" colspan="1">LVEF</td><td align="center" rowspan="1" colspan="1">0.36&#x000b1;0.03</td><td align="center" rowspan="1" colspan="1">0.33&#x000b1;0.03</td><td align="center" rowspan="1" colspan="1">0.22</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Pulmonary function</bold></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;FVC (L)</td><td align="center" rowspan="1" colspan="1">3.2&#x000b1;8.6</td><td align="center" rowspan="1" colspan="1">3.5&#x000b1;7.8</td><td align="center" rowspan="1" colspan="1">0.65</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;% predicted</td><td align="center" rowspan="1" colspan="1">83.9&#x000b1;15.08</td><td align="center" rowspan="1" colspan="1">85.4&#x000b1;16.8</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;FEV<sub>1</sub>(L)</td><td align="center" rowspan="1" colspan="1">2.78&#x000b1;7.2</td><td align="center" rowspan="1" colspan="1">2.5&#x000b1;6.3</td><td align="center" rowspan="1" colspan="1">0.34</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;% predicted</td><td align="center" rowspan="1" colspan="1">88.5&#x000b1;11.7</td><td align="center" rowspan="1" colspan="1">86&#x000b1;13.9</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;MIP (cmH<sub>2</sub>O)</td><td align="center" rowspan="1" colspan="1">57.5&#x000b1;10.2</td><td align="center" rowspan="1" colspan="1">60&#x000b1;15.1</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;% predicted</td><td align="center" rowspan="1" colspan="1">52.6&#x000b1;10.6</td><td align="center" rowspan="1" colspan="1">54.4&#x000b1;18.2</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Drug Therapy</bold></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;ACE inhibitors (mg/d)</td><td align="center" rowspan="1" colspan="1">22.3&#x000b1;11.2</td><td align="center" rowspan="1" colspan="1">23.20&#x000b1;9.3</td><td align="center" rowspan="1" colspan="1">0.37</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Furosemide (mg/d)</td><td align="center" rowspan="1" colspan="1">28.7&#x000b1;8.9</td><td align="center" rowspan="1" colspan="1">27&#x000b1;9.2</td><td align="center" rowspan="1" colspan="1">0.22</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Dobutamine (mcg/kg/min)</td><td align="center" rowspan="1" colspan="1">9.18&#x000b1;5.84</td><td align="center" rowspan="1" colspan="1">8.78&#x000b1;6.8</td><td align="center" rowspan="1" colspan="1">0.55</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Beta-blocker (mg/d)</td><td align="center" rowspan="1" colspan="1">28.12&#x000b1;10</td><td align="center" rowspan="1" colspan="1">29.14&#x000b1;11</td><td align="center" rowspan="1" colspan="1">0.42</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Laboratory tests</bold></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;NT-Pro-BNP(pg/ml)</td><td align="center" rowspan="1" colspan="1">11.789&#x000b1;2.576</td><td align="center" rowspan="1" colspan="1">10.897&#x000b1;1.998</td><td align="center" rowspan="1" colspan="1">0.44</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Functional Capacity</bold></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;6MWT (meters)</td><td align="center" rowspan="1" colspan="1">321.2&#x000b1;44</td><td align="center" rowspan="1" colspan="1">310&#x000b1;51.2</td><td align="center" rowspan="1" colspan="1">0.55</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;% predicted</td><td align="center" rowspan="1" colspan="1">55.2&#x000b1;10</td><td align="center" rowspan="1" colspan="1">61&#x000b1;9.57</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Length of exercise sessions (days)</bold></td><td align="center" rowspan="1" colspan="1">19.4&#x000b1;3.5</td><td align="center" rowspan="1" colspan="1">22.3&#x000b1;4.5</td><td align="center" rowspan="1" colspan="1">0.19</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>Values expressed as mean &#x000b1; standard deviation ACE=angiotensin
converting enzyme; BMI=body mass index; ICD=implanted cardioverter
defibrillator; FEV1=forced expiratory volume in 1 second; FVC=forced
vital capacity; LVEF=left ventricular ejection fraction; MIP =maximal
inspiratory pressure; NT-pro- BNP=Amino-terminal pro-brain natriuretic
peptide; 6MWT=6-minute walk test</p></fn></table-wrap-foot></table-wrap><p>In the overall cohort, before initiation of the study protocol, a significant
positive correlation was observed between 6MWT distance and inspiratory muscle
strength (r=0.58; <italic>P</italic>&#x0003c;0.02).</p><p>The assessment of functional capacity, for both groups, demonstrated an increase in
6MWT distance after the experimental procedure compared to the baseline. However,
only the intervention group had a statistically significant increase
(<italic>P</italic>=0.08 and <italic>P</italic>=0.001 for the control and
intervention groups, respectively). Intergroup comparison showed an increase of
15.5% (48 meters) in the intervention group compared to control (16 meters) after
completion of the study protocol (<italic>P</italic>&#x0003c;0.001) (<xref ref-type="table" rid="t2">Table 2</xref>).</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Functional capacity and maximal inspiratory pressure between groups after
protocol.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">Control Group (n=11)</th><th align="center" rowspan="1" colspan="1">Intervention Group (n=7)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">6MWT (m)</td><td align="center" rowspan="1" colspan="1">337.2&#x000b1;37.2</td><td align="center" rowspan="1" colspan="1">358&#x000b1;42.4</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">% pre</td><td align="center" rowspan="1" colspan="1">104.9&#x000b1;2</td><td align="center" rowspan="1" colspan="1">115.5&#x000b1;32</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">MIP (cmH<sub>2</sub>O)</td><td align="center" rowspan="1" colspan="1">57.5&#x000b1;12</td><td align="center" rowspan="1" colspan="1">69.6&#x000b1;14.1</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">% pre</td><td align="center" rowspan="1" colspan="1">107&#x000b1;22.2</td><td align="center" rowspan="1" colspan="1">115&#x000b1;24.2</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>Values expressed as mean &#x000b1; standard deviation.
<italic>P</italic>value refers to the difference between the groups.
% pre=considering 100% of the baseline value pre-protocol; 6MWT=6-minute
walk test; MIP=maximal inspiratory pressure</p></fn></table-wrap-foot></table-wrap><p>In regard to the inspiratory muscle strength evaluation, the intragroup analysis
demonstrated an increased strength after the protocols compared to baseline for both
groups. However, a statistically significant difference was only demonstrated in the
intervention group (<italic>P</italic>=0.22 and <italic>P</italic>&#x0003c;0.01,
respectively). Intergroup comparison revealed a significant increase of 15% in the
intervention group compared to the control group after the study protocol
(<italic>P</italic>&#x0003c;0.01) (<xref ref-type="table" rid="t2">Table
2</xref>).</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The findings of the current study indicated that a stationary cycle ergometer
exercise training program positively and significantly impacted functional
performance and respiratory muscle strength in end-stage HF patients on continuous
inotropic support awaiting heart transplantation.</p><p>Few data are available regarding the effects of exercise training in hospitalized
patients with advanced HF. In addition, there are gaps in the literature regarding
the impact of exercised-based CR in pre-cardiac transplantation patients while
receiving continuous inotropic infusion. To our knowledge, this is the first pilot
study demonstrating the effects of a stationary cycle ergometer exercise training
program on functional capacity and inspiratory muscle strength in HF patients with
this end-stage condition.</p><p>Previous studies showed that inspiratory muscle weakness is closely linked to the
deterioration of cardiac function, the impairment of the ability to exercise and
disease severity (NYHA class)<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>.</p><p>Several mechanisms are responsible for respiratory muscle weakness in patients with
HF, among them a reduction in the total number of cross-bridges between actin and
myosin and muscle cross-sectional area in the diaphragm<sup>[<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r16" ref-type="bibr">16</xref>]</sup>.
Skeletal muscle dysfunction induced by HF pathophysiology and compounded by physical
inactivity can result in a substantial decrease in strength and endurance of the
respiratory musculature. Meyer et al.<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup> showed that patients with a MIP greater than -70
cmH<sub>2</sub>O had a higher one-year mortality rate when compared to patients
with a MIP lower than -90 cm H<sub>2</sub>O. Thus, dysfunction of the respiratory
musculature is considered an independent predictor of poor prognosis in patients
with HF<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>. In the current study,
when the data were analyzed in the overall cohort at baseline, the patients showed a
MIP greater than -70 cmH<sub>2</sub>O and a significant positive correlation was
observed between 6MWT distance and inspiratory muscle strength. Therefore, patients
with a low 6MWT distance had a higher likelihood of poor inspiratory muscle
strength.</p><p>Evidence indicates that some performance modification on the 6MWT following an
intervention reflects changes in clinical functional status<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>. In this study, to evaluate
functional capacity, all patients underwent a 6MWT. This test is a simple, practical
and safe form of evaluation in HF patients, particularly those who are hospitalized,
and demonstrate advanced disease severity. In regard to submaximal functional
capacity, our results demonstrate that both groups obtained an increase in 6MWT
distance after the protocol compared to baseline; however, only the intervention
group had a statistically significant increase. When comparing groups, after the
study protocol, those participating in the cycle ergometer exercise program showed a
statistically significant greater increase (48 meters) in 6MWT distance compared to
the control group in relation to baseline. Previous studies have reported that 6MWT
distance indicates changes in a patient's functional status. A recent study found
that a change of 45 meters during the 6MWT indicates a minimal clinically
significant improvement following rehabilitation in patients with HF<sup>[<xref rid="r19" ref-type="bibr">19</xref>,<xref rid="r20" ref-type="bibr">20</xref>]</sup>. Thus, in the present study, only the cycle ergometer
exercise program group reached a meaningful clinical improvement in 6MWT
distance.</p><p>A positive impact on functional capacity and quality of life in outpatients with HF
following exercise training has been clearly established<sup>[<xref rid="r21" ref-type="bibr">21</xref>-<xref rid="r24" ref-type="bibr">24</xref>]</sup>. For
the in-hospital phase, limited published literature shows that early mobilization
with daily cycle ergometer exercise training was able to improve quadriceps strength
and functional capacity in critically ill inpatients subject to prolonged bed
rest<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup>. For HF
inpatients, a case report used a progressive, semi-independent interval-walking
program in a patient with advanced HF on continuous dobutamine therapy showed
functional improvements and the clinical utility of the 6MWT<sup>[<xref rid="r26" ref-type="bibr">26</xref>]</sup>. Similar results were reported in
another case report that used ambulation sessions and seated lower extremity
ergometer sessions<sup>[<xref rid="r27" ref-type="bibr">27</xref>]</sup>. Moreover,
Arena et al.<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup> demonstrated in a
case report that exercise training consisting of ambulation on a treadmill, lower
extremity ergometer, and resistive exercises improved aerobic exercise time and
sustainable exercise workload in an inpatient awaiting heart transplantation while
on intravenous positive inotropic support. Our study adds to this limited body of
literature, as it was the first pilot study to demonstrate that an exercised-based
training program could bring about positive and statistically significant
improvements in end-stage HF patients awaiting cardiac transplantation.</p><p>Changes in the inspiratory musculature play an important role in the pathophysiologic
milieu induced by HF and lead to oftentimes substantial exercise
limitations<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>. There is
a compelling body of evidence that indicates the degree of respiratory muscle
weakness is related to the severity of HF, functional capacity limitations, and
diminished quality of life<sup>[<xref rid="r15" ref-type="bibr">15</xref>-<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r28" ref-type="bibr">28</xref>,<xref rid="r29" ref-type="bibr">29</xref>]</sup>. It is important
to highlight that exercise training leads to a notable improvement in ventilatory
capacity, independent of the type of program - endurance exercise performed either
with constant load intensity or with interval training, combining different periods
of intensity or a program that includes resistance training sessions<sup>[<xref rid="r30" ref-type="bibr">30</xref>]</sup>. There are studies showing that
aerobic training alone can prevent diaphragm tumor necrosis factor-&#x003b1;
(TNF-&#x003b1;)-induced loss of force and significantly improve MIP in patients
with HF<sup>[<xref rid="r31" ref-type="bibr">31</xref>]</sup>. Ours results are
consistent with other studies and revealed that the intervention group had a
statistically significant increase between baseline and follow-up MIP evaluation,
reflecting improved inspiratory muscle strength.</p><p>Therefore, this study demonstrated that a stationary cycle ergometer exercise
training program could improve functional capacity and inspiratory muscle function
in hospitalized patients awaiting heart transplantation while on inotropic support.
These results support a new standard approach to the management of this HF
condition, benefiting the patient in terms of quality of life, functional capacity,
and post-surgical trajectory.</p><p>We speculate that the observed improvement in functional capacity and inspiratory
muscles function could aggregate to attain better operative outcomes at the time of
the heart transplantation surgery.</p><p>There are some important limitations to this study. Our investigation included a low
number of patients, despite being the largest so far. In the intervention group, 5
patients were excluded due to incapacity to complete the stationary cycle ergometer
exercise program without non-invasive ventilation support. Therefore, future
research is needed to further assess this type of exercise programs in HF patients
with these clinical characteristics to further support the findings reported
herein.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>This current study demonstrates that a stationary cycle ergometer exercise program
leads to positive improvements in functional capacity and inspiratory muscle
strength in patients with HF who are hospitalized and awaiting heart transplantation
while on intravenous inotropic support.</p><table-wrap id="t4" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors&#x02019; roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">PF</td><td align="left" rowspan="1" colspan="1">Conception and design study; manuscript redaction or
critical <break/>review of its content; final manuscript
approval</td></tr><tr><td align="left" rowspan="1" colspan="1">SG</td><td align="left" rowspan="1" colspan="1">Conception and design study; manuscript redaction or
critical <break/>review of its content; final manuscript
approval</td></tr><tr><td align="left" rowspan="1" colspan="1">MP</td><td align="left" rowspan="1" colspan="1">Manuscript redaction or critical review of its content;
final <break/>manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">CB</td><td align="left" rowspan="1" colspan="1">Manuscript redaction or critical review of its content;
final <break/>manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">DWB</td><td align="left" rowspan="1" colspan="1">Manuscript redaction or critical review of its content;
final <break/>manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">ISR</td><td align="left" rowspan="1" colspan="1">Manuscript redaction or critical review of its content;
final <break/>manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">VBS</td><td align="left" rowspan="1" colspan="1">Manuscript redaction or critical review of its content;
final <break/>manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">RSLM</td><td align="left" rowspan="1" colspan="1">Manuscript redaction or critical review of its content;
final <break/>manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">JRB</td><td align="left" rowspan="1" colspan="1">Manuscript redaction or critical review of its content;
final <break/>manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">DRA</td><td align="left" rowspan="1" colspan="1">Manuscript redaction or critical review of its content;
final <break/>manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">ACCC</td><td align="left" rowspan="1" colspan="1">Manuscript redaction or critical review of its content;
final <break/>manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">RA</td><td align="left" rowspan="1" colspan="1">Manuscript redaction or critical review of its content;
final <break/>manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">WJG</td><td align="left" rowspan="1" colspan="1">Manuscript redaction or critical review of its content;
final <break/>manuscript approval</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at Disciplina de Cirurgia Cardiovascular, Hospital
S&#x000e3;o Paulo, Escola Paulista de Medicina da Universidade Federal de
S&#x000e3;o Paulo (EPM-UNIFESP), S&#x000e3;o Paulo, SP, Brazil.</p></fn><fn fn-type="supported-by"><p>No financial support.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yancy</surname><given-names>CW</given-names></name><name><surname>Jessup</surname><given-names>M</given-names></name><name><surname>Bozkurt</surname><given-names>B</given-names></name><name><surname>Butler</surname><given-names>J</given-names></name><name><surname>Casey Jr</surname><given-names>DE</given-names></name><name><surname>Drazner</surname><given-names>MH</given-names></name><etal/><collab>American College of Cardiology Foundation</collab><collab>American Heart Association Task Force on Practice
Guidelines</collab></person-group><article-title>2013 ACCF/AHA guideline for the management of heart failure: a
report of the American College of Cardiology Foundation/American Heart
Association Task Force on Practice Guidelines</article-title><source>J Am Coll Cardiol</source><year>2013</year><volume>62</volume><issue>16</issue><fpage>e147</fpage><lpage>e239</lpage><pub-id pub-id-type="pmid">23747642</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro</surname><given-names>PJ</given-names></name><name><surname>Chiappa</surname><given-names>RG</given-names></name><name><surname>Callegaro</surname><given-names>CC</given-names></name></person-group><article-title>The contribution of inspiratory muscles function to exercise
limitation in heart failure: pathophysiological mechanisms.</article-title><source>Rev Bras Fisioter</source><year>2012</year><volume>16</volume><issue>4</issue><fpage>261</fpage><lpage>267</lpage><pub-id pub-id-type="pmid">22801449</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagar</surname><given-names>VA</given-names></name><name><surname>Davies</surname><given-names>EJ</given-names></name><name><surname>Briscoe</surname><given-names>S</given-names></name><name><surname>Coats</surname><given-names>AJ</given-names></name><name><surname>Dalal</surname><given-names>HM</given-names></name><name><surname>Lough</surname><given-names>FR</given-names></name><etal/></person-group><article-title>Exercise-based rehabilitation for heart failure: systematic
review and meta-analysis</article-title><source>Open Heart</source><year>2015</year><volume>2</volume><issue>1</issue><elocation-id>e000163</elocation-id><pub-id pub-id-type="pmid">25685361</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belardinelli</surname><given-names>R</given-names></name><name><surname>Georgiou</surname><given-names>D</given-names></name><name><surname>Cianci</surname><given-names>G</given-names></name><name><surname>Purcaro</surname><given-names>A</given-names></name></person-group><article-title>10-year exercise training in chronic heart failure: a randomized
controlled trial</article-title><source>J Am Coll Cardiol</source><year>2012</year><volume>60</volume><issue>16</issue><fpage>1521</fpage><lpage>1528</lpage><pub-id pub-id-type="pmid">22999730</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cattadori</surname><given-names>G</given-names></name><name><surname>Schmid</surname><given-names>JP</given-names></name><name><surname>Brugger</surname><given-names>N</given-names></name><name><surname>Gondoni</surname><given-names>E</given-names></name><name><surname>Palermo</surname><given-names>P</given-names></name><name><surname>Agostoni</surname><given-names>P</given-names></name></person-group><article-title>Hemodynamic effects of exercise training in heart
failure</article-title><source>J Card Fail</source><year>2011</year><volume>17</volume><issue>11</issue><fpage>916</fpage><lpage>922</lpage><pub-id pub-id-type="pmid">22041328</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coronel</surname><given-names>CC</given-names></name><name><surname>Bordignon</surname><given-names>S</given-names></name><name><surname>Bueno</surname><given-names>AD</given-names></name><name><surname>Lima</surname><given-names>LL</given-names></name><name><surname>Nesralla</surname><given-names>I</given-names></name></person-group><article-title>Perioperative variables of ventilatory function and physical
capacity in heart transplant patients</article-title><source>Rev Bras Cir Cardiovasc</source><year>2010</year><volume>25</volume><issue>2</issue><fpage>190</fpage><lpage>196</lpage><pub-id pub-id-type="pmid">20802910</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cipriano Jr</surname><given-names>G</given-names></name><name><surname>Yuri</surname><given-names>D</given-names></name><name><surname>Bernadelli</surname><given-names>GF</given-names></name><name><surname>Mair</surname><given-names>V</given-names></name><name><surname>Buffolo</surname><given-names>E</given-names></name><name><surname>Branco</surname><given-names>JN</given-names></name></person-group><article-title>Analysis of 6-minute walk test safety in pre-heart
transplantation patients</article-title><source>Arq Bras Cardiol</source><year>2009</year><volume>92</volume><issue>4</issue><fpage>312</fpage><lpage>319</lpage><pub-id pub-id-type="pmid">19565141</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arena</surname><given-names>R</given-names></name><name><surname>Humphrey</surname><given-names>R</given-names></name><name><surname>Peberdy</surname><given-names>MA</given-names></name></person-group><article-title>Safety and efficacy of exercise training in a patient awaiting
heart transplantation while on positive intravenous inotropic
support</article-title><source>J Cardiopulm Rehabil</source><year>2000</year><volume>20</volume><issue>4</issue><fpage>259</fpage><lpage>261</lpage><pub-id pub-id-type="pmid">10955268</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American Thoracic Society</collab></person-group><article-title>Standardization of Spirometry, 1994 Update</article-title><source>Am J Respir Crit Care Med</source><year>1995</year><volume>152</volume><issue>3</issue><fpage>1107</fpage><lpage>1136</lpage><pub-id pub-id-type="pmid">7663792</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Brazilian Society of Pneumology and Tisiology</collab></person-group><article-title>Diretrizes para teste de fun&#x000e7;&#x000e3;o pulmonar:
Press&#x000f5;es respirat&#x000f3;rias est&#x000e1;ticas
m&#x000e1;ximas</article-title><source>J Pneumol</source><year>2002</year><volume>28</volume><issue>3</issue><fpage>S1</fpage><lpage>238</lpage></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neder</surname><given-names>JA</given-names></name><name><surname>Andreoni</surname><given-names>S</given-names></name><name><surname>Lerario</surname><given-names>MC</given-names></name><name><surname>Nery</surname><given-names>LE</given-names></name></person-group><article-title>Reference values for lung function tests. II. Maximal respiratory
pressures and voluntary ventilation</article-title><source>Braz J Med Biol Res</source><year>1999</year><volume>32</volume><issue>6</issue><fpage>719</fpage><lpage>727</lpage><pub-id pub-id-type="pmid">10412550</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>ATS Committee on Proficiency Standards for Clinical Pulmonary
Function Laboratories</collab></person-group><article-title>ATS Statement: Guideline for the six walk test</article-title><source>Am J Respir Crit Care Med</source><year>2002</year><volume>166</volume><issue>1</issue><fpage>111</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">12091180</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwama</surname><given-names>AM</given-names></name><name><surname>Andrade</surname><given-names>GN</given-names></name><name><surname>Shima</surname><given-names>P</given-names></name><name><surname>Tanni</surname><given-names>SE</given-names></name><name><surname>Godoy</surname><given-names>I</given-names></name><name><surname>Dourado</surname><given-names>VZ</given-names></name></person-group><article-title>The six minute walk test and body weight-walk distance product in
health Brazilian subjects</article-title><source>Braz J Med Biol Res</source><year>2009</year><volume>42</volume><issue>11</issue><fpage>1080</fpage><lpage>1085</lpage><pub-id pub-id-type="pmid">19802464</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishimura</surname><given-names>Y</given-names></name><name><surname>Maeda</surname><given-names>H</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>H</given-names></name><name><surname>Hashimoto</surname><given-names>Y</given-names></name><name><surname>Yokoyama</surname><given-names>M</given-names></name></person-group><article-title>Respiratory muscle strength and hemodynamics in chronic heart
failure</article-title><source>Chest</source><year>1994</year><volume>105</volume><issue>2</issue><fpage>355</fpage><lpage>359</lpage><pub-id pub-id-type="pmid">8306727</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laghi</surname><given-names>F</given-names></name><name><surname>Tobin</surname><given-names>MJ</given-names></name></person-group><article-title>Disorders of the respiratory muscles</article-title><source>Am J Respir Crit Care Med</source><year>2003</year><volume>168</volume><issue>1</issue><fpage>10</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">12826594</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindsay</surname><given-names>DC</given-names></name><name><surname>Lovegrove</surname><given-names>CA</given-names></name><name><surname>Dunn</surname><given-names>MJ</given-names></name><name><surname>Bennett</surname><given-names>JG</given-names></name><name><surname>Pepper</surname><given-names>JR</given-names></name><name><surname>Yacoub</surname><given-names>MH</given-names></name><etal/></person-group><article-title>Histological abnormalities of muscle from limb, thorax and
diaphragm in chronic heart failure</article-title><source>Eur Heart J</source><year>1996</year><volume>17</volume><issue>8</issue><fpage>1239</fpage><lpage>1250</lpage><pub-id pub-id-type="pmid">8869866</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>FJ</given-names></name><name><surname>Borst</surname><given-names>MM</given-names></name><name><surname>Zugck</surname><given-names>C</given-names></name><name><surname>Kirschke</surname><given-names>A</given-names></name><name><surname>Schellberg</surname><given-names>D</given-names></name><name><surname>K&#x000fc;bler</surname><given-names>W</given-names></name><etal/></person-group><article-title>Respiratory muscle dysfunction in congestive heart failure:
clinical correlation and prognostic significance</article-title><source>Circulation</source><year>2001</year><volume>103</volume><issue>17</issue><fpage>2153</fpage><lpage>2158</lpage><pub-id pub-id-type="pmid">11331255</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bublitz</surname><given-names>C</given-names></name><name><surname>Renno</surname><given-names>MCA</given-names></name><name><surname>Ramos</surname><given-names>SR</given-names></name><name><surname>Assis</surname><given-names>L</given-names></name><name><surname>Sellera</surname><given-names>CAC</given-names></name><name><surname>Trimer</surname><given-names>R</given-names></name><etal/></person-group><article-title>Acute effects of low-level laser therapy irradiation on blood
lactate and muscle fatigue perception in hospitalized patients with heart
failure: a pilot study</article-title><source>Lasers Med Sci</source><year>2016</year><volume>31</volume><issue>6</issue><fpage>1203</fpage><lpage>1209</lpage><pub-id pub-id-type="pmid">27250713</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shoemaker</surname><given-names>MJ</given-names></name><name><surname>Curtis</surname><given-names>AB</given-names></name><name><surname>Vangsnes</surname><given-names>E</given-names></name><name><surname>Dickinson</surname><given-names>MG</given-names></name></person-group><article-title>Triangulating clinically meaningful change in the six-minute walk
test in individuals with chronic heart failure: a systematic
review</article-title><source>Cardiopulm Phys Ther J</source><year>2012</year><volume>23</volume><issue>3</issue><fpage>5</fpage><lpage>15</lpage></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shoemaker</surname><given-names>MJ</given-names></name><name><surname>Curtis</surname><given-names>AB</given-names></name><name><surname>Vangsnes</surname><given-names>E</given-names></name><name><surname>Dickinson</surname><given-names>MG</given-names></name></person-group><article-title>Clinically meaningful change estimates for the six-minute walk
test and daily activity in individuals with chronic heart
failure</article-title><source>Cardiopulm Phys Ther J</source><year>2013</year><volume>24</volume><issue>3</issue><fpage>21</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">23997688</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hambrecht</surname><given-names>R</given-names></name><name><surname>Niebauer</surname><given-names>J</given-names></name><name><surname>Fiehn</surname><given-names>E</given-names></name><name><surname>K&#x000e4;lberer</surname><given-names>B</given-names></name><name><surname>Offner</surname><given-names>B</given-names></name><name><surname>Hauer</surname><given-names>K</given-names></name><etal/></person-group><article-title>Physical training in patients with stable chronic heart failure:
effects on cardiorespiratory fitness and ultrastructural abnormalities of
leg muscles</article-title><source>J Am Coll Cardiol</source><year>1995</year><volume>25</volume><issue>6</issue><fpage>1239</fpage><lpage>1249</lpage><pub-id pub-id-type="pmid">7722116</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>RS</given-names></name><name><surname>Sagar</surname><given-names>VA</given-names></name><name><surname>Davies</surname><given-names>EJ</given-names></name><name><surname>Briscoe</surname><given-names>S</given-names></name><name><surname>Coats</surname><given-names>AJ</given-names></name><name><surname>Dalal</surname><given-names>H</given-names></name><etal/></person-group><article-title>Exercisebased rehabilitation for heart failure</article-title><source>Cochrane Database Syst Rev</source><year>2014</year><volume>27</volume><issue>4</issue><elocation-id>CD003331</elocation-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silveira</surname><given-names>FD</given-names></name><name><surname>Ribeiro</surname><given-names>LJ</given-names></name><name><surname>Ramis</surname><given-names>RT</given-names></name></person-group><article-title>Treinamento intermitente na reabilita&#x000e7;&#x000e3;o de
pacientes com insufici&#x000ea;ncia card&#x000ed;aca:
revis&#x000e3;o sistem&#x000e1;tica</article-title><source>Rev Bras Cardiol</source><year>2012</year><volume>25</volume><issue>5</issue><fpage>418</fpage><lpage>427</lpage></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babu</surname><given-names>AS</given-names></name><name><surname>Maiya</surname><given-names>AG</given-names></name><name><surname>George</surname><given-names>MM</given-names></name><name><surname>Padmakumar</surname><given-names>R</given-names></name><name><surname>Guddattu</surname><given-names>V</given-names></name></person-group><article-title>Effects of combined early in-patient cardiac rehabilitation and
structured homebased program on function among patients with congestive
heart failure: a randomized controlled trial</article-title><source>Heart Views</source><year>2011</year><volume>12</volume><issue>3</issue><fpage>99</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">22567195</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burtin</surname><given-names>C</given-names></name><name><surname>Clerckx</surname><given-names>B</given-names></name><name><surname>Hermans</surname><given-names>G</given-names></name><name><surname>Gosselink</surname><given-names>R</given-names></name></person-group><article-title>Early exercise in critically ill patients enhances short-term
functional recovery</article-title><source>Crit Care Med</source><year>2009</year><volume>37</volume><issue>9</issue><fpage>2499</fpage><lpage>2450</lpage><pub-id pub-id-type="pmid">19623052</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ricard</surname><given-names>PEH</given-names></name><name><surname>Camarda</surname><given-names>R</given-names></name><name><surname>Foley</surname><given-names>LL</given-names></name><name><surname>Givertz</surname><given-names>MM</given-names></name><name><surname>Cahalin</surname><given-names>PL</given-names></name></person-group><article-title>Case report: exercise in a patient with acute decompensated heart
failure receiving positive inotropic therapy</article-title><source>Cardiopulm Phys Ther J</source><year>2011</year><volume>22</volume><issue>2</issue><fpage>13</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">21637393</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macauley</surname><given-names>K</given-names></name></person-group><article-title>Physical therapy management of two patients with stage D heart
failure in the cardiac medical intensive care unit</article-title><source>Cardiopulm Phys Ther J</source><year>2012</year><volume>23</volume><issue>3</issue><fpage>37</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">22993501</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponikowski</surname><given-names>P</given-names></name><name><surname>Francis</surname><given-names>DP</given-names></name><name><surname>Piepoli</surname><given-names>MF</given-names></name><name><surname>Davies</surname><given-names>LC</given-names></name><name><surname>Chua</surname><given-names>TP</given-names></name><name><surname>Davos</surname><given-names>CH</given-names></name><etal/></person-group><article-title>Enhanced ventilatory response to exercise in patients with
chronic heart failure and preserved exercise tolerance: marker of abnormal
cardiorespiratory reflex control and predictor of poor
prognosis</article-title><source>Circulation</source><year>2001</year><volume>103</volume><issue>7</issue><fpage>967</fpage><lpage>972</lpage><pub-id pub-id-type="pmid">11181471</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelley</surname><given-names>RC</given-names></name><name><surname>Ferreira</surname><given-names>LF</given-names></name></person-group><article-title>Diaphragm abnormalities in heart failure and aging: mechanisms
and integration of cardiovascular and respiratory
pathophysiology</article-title><source>Heart Fail Rev</source><day>21</day><month>3</month><year>2016</year><comment>Epub ahead of print</comment></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabet</surname><given-names>JY</given-names></name><name><surname>Meurin</surname><given-names>P</given-names></name><name><surname>Driss</surname><given-names>AB</given-names></name><name><surname>Weber</surname><given-names>H</given-names></name><name><surname>Renaud</surname><given-names>N</given-names></name><name><surname>Grosdemouge</surname><given-names>A</given-names></name><etal/></person-group><article-title>Benefits of exercise training in chronic heart
failure</article-title><source>Arch Cardiovasc Dis</source><year>2009</year><volume>102</volume><issue>10</issue><fpage>721</fpage><lpage>730</lpage><pub-id pub-id-type="pmid">19913773</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mangner</surname><given-names>N</given-names></name><name><surname>Linke</surname><given-names>A</given-names></name><name><surname>Oberbach</surname><given-names>A</given-names></name><name><surname>Kullnick</surname><given-names>Y</given-names></name><name><surname>Gielen</surname><given-names>S</given-names></name><name><surname>Sandri</surname><given-names>M</given-names></name><etal/></person-group><article-title>Exercise training prevents TNF-&#x003b1; induced loss of force
in the diaphragm of mice</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>1</issue><elocation-id>e52274</elocation-id><pub-id pub-id-type="pmid">23300968</pub-id></element-citation></ref></ref-list></back></article>